ArticleMolecular neurobiology2026
Role of Sigma-1 Receptors in the Paraventricular Nucleus and Myocardium during Cirrhotic Cardiomyopathy in Rats.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the alterations in Sigma-1 receptor (Sigma-1R) expression in the paraventricular nucleus (PVN) of the hypothalamus and in the myocardium during the development of bile duct ligation-induced cirrhotic cardiomyopathy (CCM) in rats. Furthermore, we sought to determine the impact of Sigma-1R overexpression in the PVN on the progression of CCM and its potential associations with sympathetic nervous system activity and endoplasmic reticulum stress. Additionally, changes in dopamine D1 receptor (D1R) expression in CCM were examined. Our findings indicate that CCM is associated with upregulated Sigma-1R expression in both the PVN and myocardium, as well as with excessive endoplasmic reticulum stress in the hypothalamic PVN and myocardial tissue, along with increased peripheral sympathetic activity. Overexpression of Sigma-1R in the PVN exacerbates CCM, likely through enhancing endoplasmic reticulum stress within the PVN and increasing central and peripheral sympathetic outflow. Moreover, CCM is also linked to upregulation of D1R in both central and cardiac regions. These results suggest that Sigma-1R may modulate central sympathetic output via D1R signaling, thereby influencing the pathogenesis and progression of CCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.